Even geduld alstublieft, we laden de grafiekgegevens
AstraZeneca PLC-community
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is € 150,55, with a 24-hour trading volume of € 487,32M. The asset's market cap is € 233,49B, after moving -3.85% in the last day.
Tokenized AstraZeneca PLC is trading at € 86,87, with a tokenized market cap of € 49,18M and a 24-hour trading volume of € 666,99K. The tokenized asset has moved 2.33% in the past 24 hours.